Scientists at the National University of Singapore’s Yong Loo Lin School of Medicine (NUS Medicine) have uncovered a groundbreaking molecular mechanism that could revolutionize our understanding of brain aging and cognitive decline. Their research identifies a protein that reactivates the brain’s ability to generate new nerve cells, offering hope for treatments targeting age-related neurological deterioration.
The discovery centers on cyclin D-binding myb-like transcription factor 1 (DMTF1), a protein that acts as a molecular switch controlling neural stem cell regeneration. Published in Science Advances, this research reveals how aging brains can potentially maintain their regenerative capacity despite the natural decline that typically accompanies advancing years.
Understanding Neural Stem Cell Decline in Aging
Neural stem cells serve as the brain’s regenerative reserve, producing new neurons essential for learning, memory, and cognitive function. However, as we age, these stem cells progressively lose their ability to regenerate, contributing to cognitive decline and increased vulnerability to neurodegenerative conditions.
Assistant Professor Ong Sek Tong Derrick led the research team from the Department of Physiology and the Healthy Longevity Translational Research Programme at NUS Medicine. Working alongside first author Dr. Liang Yajing, the team investigated why neural stem cells lose regenerative capacity over time and identified potential reversal strategies.
The Role of Transcription Factors
Transcription factors function as genetic regulators, determining when specific genes activate and ensuring proper cellular behavior. DMTF1 emerged as a pivotal player in maintaining neural stem cell activity throughout the aging process, positioning it as a critical target for therapeutic interventions.
DMTF1’s Mechanism in Brain Regeneration
The research team employed sophisticated analytical techniques to understand DMTF1’s function. Using human neural stem cells and laboratory models engineered to replicate premature aging, they conducted genome binding and transcriptome analyses. These methods revealed where DMTF1 operates across the genome and how it modifies gene activity patterns.
Telomere Connection to Neural Aging
The investigation focused on DMTF1’s behavior in neural stem cells with damaged telomeres—the protective chromosome caps that shorten with each cell division. Telomere shortening represents a well-established hallmark of cellular aging and plays a crucial role in age-related decline.
Researchers observed significantly reduced DMTF1 levels in aged neural stem cells. Remarkably, simply reactivating DMTF1 alone restored the cells’ regenerative abilities, demonstrating its potential as a therapeutic target for maintaining brain function during aging.
Discovery of Helper Gene Regulation
The study unveiled an unexpected function of DMTF1: regulating helper genes Arid2 and Ss18. These genes make DNA more accessible and activate additional genes involved in cell growth and division. Without proper DMTF1 regulation, these helper genes malfunction, causing neural stem cells to lose their self-renewal capacity.
Implications for Cognitive Health and Memory
“Impaired neural stem cell regeneration has long been associated with neurological aging,” explained Assistant Professor Ong. “Inadequate neural stem cell regeneration inhibits the formation of new cells needed to support learning and memory functions.” He emphasized that understanding these regeneration mechanisms provides a stronger foundation for studying age-related cognitive decline.
The findings suggest that therapeutic approaches enhancing DMTF1 expression or activity could reverse or delay aging-associated decline in neural stem cell function, offering new avenues for treating age-related cognitive impairment.
Future Research Directions and Therapeutic Potential
While current findings derive primarily from laboratory experiments, researchers plan to explore whether elevating DMTF1 expression can regenerate neural stem cell populations and improve learning and memory under conditions of telomere shortening and natural aging—without increasing brain tumor risk.
The long-term goal involves discovering small molecules that enhance DMTF1 expression and activity, improving aged neural stem cell function. “Our findings suggest that DMTF1 can contribute to neural stem cell multiplication in neurological aging,” stated Dr. Liang. “While our study is in its infancy, the findings provide a framework for understanding how aging-associated molecular changes affect neural stem cell behavior, and may ultimately guide the development of successful therapeutics.”
This research represents a significant advancement in neurological aging science, offering promising pathways toward maintaining cognitive vitality throughout the human lifespan.
